ArticleJournal of thoracic disease2013
Lymphangioleiomyomatosis: current and future.
Article in Journal of thoracic disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 25 citations in OpenAlex.
- Case report: If it is not asthma-think of lymphangioleiomyomatosis in younger female patients.Frontiers in medicine · 2024Article
- Benign metastasizing uterine leiomyoma with lymphatic and pulmonary metastases: a case report and literature review.BMC women's health · 2023Review
- Pulmonary lymphangioleiomyomatosis: a case report.International journal of clinical and experimental pathology · 2019Article
- Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis.Caspian journal of internal medicine · 2019Article
- Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment.OncoTargets and therapy · 2018Article
- Pelvic lymphangioleiomyomatosis treated successfully with everolimus: Two case reports with literature review.Medicine · 2017Review
- Sporadic lymphangioleiomyomatosis with bloody sputum as an initial symptom: A case report and review of the literature.Experimental and therapeutic medicine · 2015Article
- TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.Orphanet journal of rare diseases · 2014Article
- Extrapulmonary lymphangioleiomyoma: clinicopathological analysis of 4 cases.Korean journal of pathology · 2014Article
- Effusion cytology: an effective method for the diagnosis of pulmonary lymphangioleiomyomatosis.Journal of thoracic disease · 2014Article
- Chyloptysis causing plastic bronchitis.Respiratory medicine case reports · 2014Article
- Lymphangioleiomyomatosis diagnosed by effusion cytology: A case report.Journal of cytologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphangioleiomyomatosis is a rare slowly progressive lung disease that affects almost exclusively young women of reproductive age. It occurs sporadically or in association with Tuberous Sclerosis Complex. LAM is characterized by cystic remodeling of the lung parenchyma, due to proliferation of abnormal smooth muscle-like LAM cells and presence of extra pulmonary manifestations such as lymphadenopathy, angiomyolipomas and abdominal lymphangioleiomyomas. The most common clinical manifestations are progressive dyspnea on exertion, pneumothorax and chylous effusions. Currently there is no curative treatment for the disease, but the ongoing study of the genetic and molecular pathways implicated in the pathogenesis of the disease could lead to targeted therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.